PlainRecalls
FDA Drug Moderate Class II Terminated

Daunorubicin Hydrochloride Injection, 20 mg/4 mL (5 mg/mL), 4 mL Single Dose Vial, Rx ONLY, For IV Use Only, Manufactured By: Teva parenteral Medicines, Inc., Irvine, CA NOVAPlus¿¿ labels. NDC 0703-5233-13 (carton), NDC 0703-5233-11 (vial) or NDC 0703-5233-93 (carton), NDC 0703-5233-91 (vial)

Reported: January 8, 2014 Initiated: October 11, 2013 #D-392-2014

Product Description

Daunorubicin Hydrochloride Injection, 20 mg/4 mL (5 mg/mL), 4 mL Single Dose Vial, Rx ONLY, For IV Use Only, Manufactured By: Teva parenteral Medicines, Inc., Irvine, CA NOVAPlus¿¿ labels. NDC 0703-5233-13 (carton), NDC 0703-5233-11 (vial) or NDC 0703-5233-93 (carton), NDC 0703-5233-91 (vial)

Reason for Recall

Presence of Precipitate; precipitation of drug product

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
13520 vials
Distribution
Nationwide
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
Daunorubicin Hydrochloride Injection, 20 mg/4 mL (5 mg/mL), 4 mL Single Dose Vial, Rx ONLY, For IV Use Only, Manufactured By: Teva parenteral Medicines, Inc., Irvine, CA NOVAPlus¿¿ labels. NDC 0703-5233-13 (carton), NDC 0703-5233-11 (vial) or NDC 0703-5233-93 (carton), NDC 0703-5233-91 (vial). Recalled by Teva Pharmaceuticals USA. Units affected: 13520 vials.
Why was this product recalled?
Presence of Precipitate; precipitation of drug product
Which agency issued this recall?
This recall was issued by the FDA Drug on January 8, 2014. Severity: Moderate. Recall number: D-392-2014.